Focal Epilepsy With and Without Secondary Generalization
Neurology
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
UP
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
IQVIACenobamate
UCB PharmaLacosamide
Clinical Trials (2)
Total enrollment: 615 patients across 2 trials
Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain
Start: Dec 2024Est. completion: Mar 2027300 patients
N/ARecruiting
Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy
Start: Jul 2012Est. completion: Jul 2015315 patients
N/ACompleted
Related Jobs in Neurology
Specialty Account Manager, Symbravo (Queens, NY)
Axsome Therapeutics
Queens, NY
18h ago
$100K - $150K/yr
Specialist Quality Services (Product Complaints)
Sanofi
Hyderabad
Yesterday
Digital Product Lead - iCare Connect
Sanofi
Cambridge, MA
Yesterday
$134K - $193K/yr
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
Yesterday
$208K - $234K/yr
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
Yesterday
Electronics Engineering Manager
CoMind
London, UK
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 615 patients
2 companies competing in this space